TCL Archive In Senate testimony, NCI director uses survival rate as measure of progress for goal to “eliminate suffering and death due to cancer.” July 29, 2005
TCL Archive Mammography For Women Under 50 Debated; Cut Of 3-4% Offered As Budget Trimmer July 23, 1976
TCL Archive FDA unlikely to pull Iressa from market. Iressa a case study in how not to develop a drug, ODAC member says. April 1, 2005
